The global nanoparticles - metal & metal oxide market size is estimated to register a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing usage in fuel additives, rising demand for personal care products, and growing application of nano-metal oxide in paints & coating, and aerospace.
Nanoparticles refer to the particles with a size of 1 to 100 nanometers. Nanoparticles have exceptional properties in terms of physical, chemical, and surface qualities, allowing them to be used in a variety of fields including chemicals & coatings, electrical & electronics, automobiles, maritime, aviation, pharmaceuticals & healthcare, cosmetics & personal care, and military. The majority of manufactured nanomaterials come in a variety of forms, sizes, compositions, surface coatings, and morphologies. These materials have anti-corrosion, antibacterial, easy-clean, thermal barrier, protective, and UV-absorbent properties, as well as combinations of these properties.
Rising production cost, dynamic regulatory standards, and expanding demand for effective healthcare infrastructure are some of the major concerns that continuously putting pressure on the pharmaceutical industry to meet the unmet demand of the population. Thus, nanoparticle technologies have been identified as a lucrative revenue generating source due to the abovementioned concerns, as they have tremendous potential to aid disease management.
Market Trends, Drivers, Restraints, and Opportunities
- Growing adoption of nanotechnology across many end-user industries is one of the major factors propelling the market growth.
- Increasing usage of metal oxide nanoparticles for the treatment of hyperthermia disease and development of advanced diagnostic tools are expected to boost the growth of the market in coming years.
- Rising use of copper instead of silver for the manufacturing of antibacterial fabrics is fueling the market growth.
- Ongoing R&D projects for the improvement of nanoparticles technology is estimated to boost the market growth.
- Stricter government regulations on using of copper nanoparticles in order to prevent the environment from harmful effects is expected to hamper the market growth in near future.
Scope of the Report
The report on the global nanoparticles - metal & metal oxides market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Nanoparticles - Metal & Metal Oxides Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2020
|
|
Historic Data
|
2018–2019
|
|
Forecast Period
|
2021–2028
|
|
Segmentation
|
Types (Iron, Oxide, Gadolinium, Cerium, Alumina, Gold, and Silver) and Applications (Proton Therapy, In-vivo Imaging, Targeted Drug, In-vitro assays, and Others)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Pfizer Inc.; Nanoshel LLC.; Nanobiotix, nanoComposix; AstraZeneca; Nanophase Technologies Corp.; Merck KGaA; Immunolight LLC; American Elements; Nanospectra Biosciences, Inc.; Brigham and Women's Hospital (BWH); Diamon-Fusion International. Inc.; and Advanced Nano Products Co. Ltd.
|
Market Segment Insights
Gold nanoparticles segment is expected to expand at a rapid pace
Based on types, the global nanoparticles - metal & metal oxide market is segmented into iron, oxide, gadolinium, cerium, alumina, gold, silver, and others. The gold segment is expected to expand at a rapid pace during the forecast period. The growth of the segment is attributed to the growing adoption of human therapeutic development due to the tunable stability, low toxicity, and better compatibility in gold particles. Furthermore, gold nanocages covered with a temperature-sensitive polymer can be used in targeted drug administration by releasing effectors when they interact with near-infrared radiation. These effectors are effective in enabling efficient drug interaction control and monitoring. Thus, it is used in a variety of disease monitoring, drug delivery application, diagnosis, and imaging ranging from DNA to cellular level.
On the other hand, the alumina segment is anticipated to gain considerable market share during the forecast period due to its high porosity property in the membranes. Aluminum oxide in combination with polymeric membranes is being explored for drug delivery augmentation.
In-vivo imaging segment is projected to expand at a considerable CAGR
On the basis of applications, the market is segregated as proton therapy, in-vivo imaging, targeted drug, in-vitro assays, and others. The in-vivo imaging segment is projected to expand at a considerable CAGR during the forecast period owing to the increasing use of nanoshells such as Au3Cu1, which are testified to provide better contrast for blood arteries and could be used for in vivo Magnetic Resonance Angiography (MRA). In addition, AuNPs function as probes for visual monitoring of protease and protease inhibitor activity in vivo and in vitro.
On the other hand, the targeted drug segment is estimated to expand at a fast rate due to current research and development for drug delivery applications using nanotechnology. The development of photo-modulated nanoshells for medication delivery is expected to fuel the technological adoption and this is likely to further accelerate the segment growth.
North America is anticipated to constitute a key market share
In terms of regions, the global nanoparticles - metal & metal oxides market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key market share during the forecast period owing to the effective regulatory policies for medicinal development as well as Inter-country collaboration on the use and manufacture of nanoparticles. For example, through the Regulatory Cooperation Council (RCC), the United States and Canada collaborated on nanoparticles. As a result, in January 2014, a conference was held in Washington, DC in order to make arrangements for the region's nanotechnology work plan.
On the other hand, the market of Asia Pacific is expected to account for a substantial market share in the coming years. The growth of the region is attributed to the increasing investment in nanoparticle development and growing number of clinical studies to evaluate the toxicity of these nanoparticles.
Segments
Segments Covered in the Report
The global nanoparticles - metal & metal oxides market has been segmented on the basis of
Types
- Iron
- Oxide
- Gadolinium
- Cerium
- Alumina
- Gold
- Silver
- Others
Applications
- Proton Therapy
- In-vivo Imaging
- Targeted Drug
- In-vitro Assays
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Pfizer Inc.
- Nanoshel LLC.
- Nanobiotix
- nanoComposix
- AstraZeneca
- Nanophase Technologies Corp.
- Merck KGaA
- Immunolight LLC
- American Elements
- Nanospectra Biosciences, Inc.
- Brigham and Women's Hospital (BWH)
- Diamon-Fusion International. Inc.
- Advanced Nano Products Co. Ltd.
Competitive Landscape
Some of the major players competing in the global nanoparticles- metal & metal oxides market are Pfizer Inc.; Nanoshel LLC.; Nanobiotix, nanoComposix; AstraZeneca; Nanophase Technologies Corp.; Merck KGaA; Immunolight LLC; American Elements; Nanospectra Biosciences, Inc.; Brigham and Women's Hospital (BWH); Diamon-Fusion International. Inc.; and Advanced Nano Products Co. Ltd.
These major players are implementing various marketing strategies such as capital investments, merger & acquisitions, and new product development to enhance their market position in the regional as well as global competition.
Request For Customization
Enquiry Before Buying
Speak With Analyst
